Profil
Troy Hamilton formerly worked at Synergy Pharmaceuticals LLC, as Chief Executive Officer & Director from 2017 to 2019, Ellodi Pharmaceuticals, as Chief Executive Officer & Director from 2020 to 2024, and Shire Pharmaceuticals, Inc., as Vice President-Product Strategy.
Mr. Hamilton received his Masters Business Admin degree from St. Joseph's University and undergraduate degree from the University of the Sciences in Philadelphia.
Anciens postes connus de Troy Hamilton
| Sociétés | Poste | Fin |
|---|---|---|
Ellodi Pharmaceuticals
Ellodi Pharmaceuticals BiotechnologyHealth Technology Develops novel therapy for the treatment of eosinophilic esophagitis | Directeur Général | 01/11/2024 |
| SYNERGY PHARMACEUTICALS INC | Directeur Général | 01/05/2019 |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Formation de Troy Hamilton
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
St. Joseph's University
St. Joseph's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of the Sciences in Philadelphia
University of the Sciences in Philadelphia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Synergy Pharmaceuticals LLC
Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops drugs to treat gastrointestinal disorders and diseases | Health Technology |
Ellodi Pharmaceuticals
Ellodi Pharmaceuticals BiotechnologyHealth Technology Develops novel therapy for the treatment of eosinophilic esophagitis | Health Technology |
















